| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/21/2013 | US20130071420 Yeast-based vaccines as immunotherapy |
| 03/21/2013 | US20130071413 Targeted immune conjugates |
| 03/21/2013 | US20130071411 Iap bir domain binding compounds |
| 03/21/2013 | US20130071409 ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells |
| 03/21/2013 | US20130071399 Immunogen and Antivenom Against Violin Spider Venom |
| 03/21/2013 | US20130071342 Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care |
| 03/21/2013 | US20130071335 X-ray contrast media compositions and methods of using the same |
| 03/21/2013 | US20130071323 Therapies for hematologic malignancies |
| 03/21/2013 | US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 03/21/2013 | CA2848403A1 Hyr1-derived compositions and methods of treatment using same |
| 03/20/2013 | EP2570484A1 Influenza virus-like particles (VLPS) comprising hemagglutinin |
| 03/20/2013 | EP2570136A2 Protein A compositions and methods of use |
| 03/20/2013 | EP2569327A1 Eif4e binding peptides |
| 03/20/2013 | EP2569326A2 Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |
| 03/20/2013 | EP2569298A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 03/20/2013 | EP2569294A1 Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569006A2 The n-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
| 03/20/2013 | EP2568962A1 A sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (dmard) and an anti-cancer agent |
| 03/20/2013 | EP2345670B1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
| 03/20/2013 | CN1541107B Growth factor complex |
| 03/20/2013 | CN102985425A Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 03/20/2013 | CN102985424A 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases |
| 03/20/2013 | CN102985421A Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases |
| 03/20/2013 | CN102985418A Apoptosis signal-regulating kinase inhibitors |
| 03/20/2013 | CN102985107A Immunogenic influenza composition |
| 03/20/2013 | CN102985106A Methods and compositions for treating Degos' disease |
| 03/20/2013 | CN102985105A Nutritional Formulas Containing Synbiotics |
| 03/20/2013 | CN102984957A Array of age-tailored nutritional formula with optimum fat content |
| 03/20/2013 | CN102978277A Assays and methods using biomarkers |
| 03/20/2013 | CN102978089A Health care wine and preparation method thereof |
| 03/20/2013 | CN102977218A Method for extracting polysaccharide from buckwheat brans |
| 03/20/2013 | CN102977213A Monoclonal antibodies against NKG2A |
| 03/20/2013 | CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production |
| 03/20/2013 | CN102977205A Novel osteoprotegerin variant proteins |
| 03/20/2013 | CN102977175A Application of glucosamine derivatives as small molecule drug kidney-targeting modifying groups |
| 03/20/2013 | CN102977114A Inoscavin A as a monomeric component in phellinus as well as prepearation method and application thereof |
| 03/20/2013 | CN102976943A Alpha-crystal form substance of danshinolic acid A, preparation method, pharmaceutical composition and application |
| 03/20/2013 | CN102973928A Compositions and methods for priming monocytic dendritic cells and T cells for TH-1 response |
| 03/20/2013 | CN102973869A Chinese medicinal preparation for improving immunity, diminishing inflammation, removing stasis and eliminating toxicity |
| 03/20/2013 | CN102973858A Itching-relieving anti-allergy Chinese traditional medicine compound navel patch |
| 03/20/2013 | CN102973826A Chinese laxative drug for removing fire factor |
| 03/20/2013 | CN102973819A Traditional Chinese medicine prescription for treatment of allergic purpura |
| 03/20/2013 | CN102973814A Formula of traditional Chinese medicine capable of purifying blood, protecting heart and brain, and enhancing immunity, and preparation method thereof |
| 03/20/2013 | CN102973803A Drug for treating hematopathy primary thrombocytopenic purpura |
| 03/20/2013 | CN102973730A Chinese medicament for animals with functions of clearing heat and removing toxicity, resisting virus and improving body immunity and preparation method thereof |
| 03/20/2013 | CN102973725A Lentinan capsules |
| 03/20/2013 | CN102973723A Traditional Chinese medicine formulas for prevention and treatment of koi diseases |
| 03/20/2013 | CN102973685A Anti-fatigue traditional Chinese medicine preparation and preparation method thereof |
| 03/20/2013 | CN102973642A Chinese medicine composition for enhancing poultry immunity and preparation method thereof |
| 03/20/2013 | CN102973636A Common threewingnut root microemlusion-based gel preparation and preparation method thereof |
| 03/20/2013 | CN102973616A High-bioactivity ganoderma spore oil and supercritical preparation method thereof |
| 03/20/2013 | CN102973615A Composite capable of enhancing human body immunity |
| 03/20/2013 | CN102973603A 转移因子胶囊 Transfer Factor Capsule |
| 03/20/2013 | CN102973586A Fishery chitosan immunoenhancer |
| 03/20/2013 | CN102973552A Application of blumea balsamifera |
| 03/20/2013 | CN102973528A Calcitriol solid lipidic dispersion and preparation method thereof |
| 03/20/2013 | CN102973521A Poultry transfer factor nanoparticle and preparation method thereof |
| 03/20/2013 | CN102973508A Compound astragalus polysaccharide liposome long-acting injection and preparation method thereof |
| 03/20/2013 | CN102973479A Manufacturing method of facial mask paper |
| 03/20/2013 | CN102973476A Whitening antiallergic mask |
| 03/20/2013 | CN102973442A Anti-allergy skin protection cream |
| 03/20/2013 | CN102973417A Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 03/20/2013 | CN102492020B Pidotimod compound and new preparation method thereof |
| 03/20/2013 | CN102430031B Traditional Chinese medicine composition for strengthening vitality and invigorating kidneys and preparation method thereof |
| 03/20/2013 | CN102335347B Panax pseudo-ginseng and panax quinquefolium soft capsules |
| 03/20/2013 | CN102302625B Medicament for treating infantile eczema |
| 03/20/2013 | CN102198155B Production method of pig spleen transfer factor injection |
| 03/20/2013 | CN102178847B Vacuum freeze-drying processing method of dendrobium officinale |
| 03/20/2013 | CN102178699B Preparation for enhancing human immunity and promoting growth and development |
| 03/20/2013 | CN102093250B Refining method of alanyl-glutamine compound |
| 03/20/2013 | CN102002050B Bisbenzylisoquinoline derivative and preparation and application thereof |
| 03/20/2013 | CN101862028B Wintergreen extraction method, preparation method of cigarette comprising wintergreen extract |
| 03/20/2013 | CN101838307B K2 polypeptide synthesis product and application thereof |
| 03/20/2013 | CN101838306B K4 polypeptide synthesis product and application thereof |
| 03/20/2013 | CN101768565B Bacillus anthracis capable of displaying PAD4 protein on surface of spore and application thereof |
| 03/20/2013 | CN101687819B Novel preparation for external use |
| 03/20/2013 | CN101674841B Anti-histamine substance and method for production thereof |
| 03/20/2013 | CN101654664B Fermentation production method and application of high-yield exopolysaccharide strain and amylase thereof |
| 03/20/2013 | CN101648865B Polyphenol acrylic acid derivative and application thereof in medicaments |
| 03/20/2013 | CN101619305B Antihuman CD52 monoclonal antibody hybridoma cell line, monoclonal antibody, engineered antibody, carrier, reagent kit and application thereof |
| 03/20/2013 | CN101585792B Preparation method of a piglet intestinal canal barrier function controlling substance -N-acetylcysteine |
| 03/20/2013 | CN101522716B High affinity human antibodies to human IL-4 receptor |
| 03/20/2013 | CN101429164B Levorotation benzhydryl piperazidine derivant and preparing method thereof |
| 03/20/2013 | CN101371918B Novel use of oxidation resistance dipeptide in fish extract polypeptide |
| 03/20/2013 | CN101365702B Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 03/20/2013 | CN101313749B Male silk moth capsule and its preparing process |
| 03/19/2013 | US8399479 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/19/2013 | US8398980 Subtypes of humanized antibody against interleuken-6 receptor |
| 03/19/2013 | CA2706872C Intermediates for the preparation of lipoxin a4 analogs |
| 03/19/2013 | CA2534313C Formulations containing an immune response modifier |
| 03/19/2013 | CA2471702C Human monoclonal antibodies against cd30 |
| 03/19/2013 | CA2354638C Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/19/2013 | CA2311647C Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 03/19/2013 | CA2195334C Compositions and methods for enhanced tumor cell immunity in vivo |
| 03/14/2013 | WO2013036530A1 3-(4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators |
| 03/14/2013 | WO2013036302A1 Induced tolerogenic dendritic cells for generating cd8+ regulatory t cells |
| 03/14/2013 | WO2013036301A1 Induced tolerogenic dendritic cells for inducing regulatory b cells |
| 03/14/2013 | WO2013036300A1 Compositions and methods related to induced tolerogenic dedritic cells externally loaded with mhc class i-restricted epitopes |
| 03/14/2013 | WO2013036299A1 Transplantable graft-specific induced tolerogenic dendritic cells and methods of use |